-
1
-
-
0032500727
-
Outcomes research: Measuring the end results of health care
-
Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science 1998;282:245-246.
-
(1998)
Science
, vol.282
, pp. 245-246
-
-
Clancy, C.M.1
Eisenberg, J.M.2
-
2
-
-
0038440780
-
The assessment of health status among patients with COPD
-
Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J Suppl 2003;41:36s-45s.
-
(2003)
Eur Respir J Suppl
, vol.41
-
-
Curtis, J.R.1
Patrick, D.L.2
-
3
-
-
0031992445
-
Comparing generic and disease-specific measures of physical and role functioning: Results from the Veterans Health Study
-
Ren XS, Kazis L, Lee A, Miller DR, Clark JA, Skinner K, Rogers W. Comparing generic and disease-specific measures of physical and role functioning: results from the Veterans Health Study. Med Care 1998;36:155-166.
-
(1998)
Med Care
, vol.36
, pp. 155-166
-
-
Ren, X.S.1
Kazis, L.2
Lee, A.3
Miller, D.R.4
Clark, J.A.5
Skinner, K.6
Rogers, W.7
-
4
-
-
0023262407
-
A measure of quality of life for clinical trials in chronic lung disease
-
Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-778.
-
(1987)
Thorax
, vol.42
, pp. 773-778
-
-
Guyatt, G.H.1
Berman, L.B.2
Townsend, M.3
Pugsley, S.O.4
Chambers, L.W.5
-
5
-
-
0026871146
-
A self-complete measure of health status for chronic airflow limitation: The St. George's Respiratory Questionnaire
-
Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
-
(1992)
Am Rev Respir Dis
, vol.145
, pp. 1321-1327
-
-
Jones, P.W.1
Quirk, F.H.2
Baveystock, C.M.3
Littlejohns, P.4
-
6
-
-
0033017445
-
Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation
-
Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-192.
-
(1999)
J Clin Epidemiol
, vol.52
, pp. 187-192
-
-
Guyatt, G.H.1
King, D.R.2
Feeny, D.H.3
Stubbing, D.4
Goldstein, R.S.5
-
7
-
-
0031945935
-
Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease
-
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:785-790.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 785-790
-
-
Hajiro, T.1
Nishimura, K.2
Tsukino, M.3
Ikeda, A.4
Koyama, H.5
Izumi, T.6
-
8
-
-
0031768356
-
Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease
-
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1185-1189.
-
(1998)
Am J Respir Crit Care Med
, vol.158
, pp. 1185-1189
-
-
Hajiro, T.1
Nishimura, K.2
Tsukino, M.3
Ikeda, A.4
Koyama, H.5
Izumi, T.6
-
9
-
-
0024427075
-
Measuring functional status in chronic lung disease: Conclusions from a randomized control trial
-
Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 1989;83:293-297.
-
(1989)
Respir Med
, vol.83
, pp. 293-297
-
-
Guyatt, G.H.1
Townsend, M.2
Keller, J.3
Singer, J.4
Nogradi, S.5
-
10
-
-
0024852022
-
Measurement of health status: Ascertaining the minimal clinically important difference
-
Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-415.
-
(1989)
Control Clin Trials
, vol.10
, pp. 407-415
-
-
Jaeschke, R.1
Singer, J.2
Guyatt, G.H.3
-
11
-
-
0030603333
-
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
-
Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-1119.
-
(1996)
Lancet
, vol.348
, pp. 1115-1119
-
-
Lacasse, Y.1
Wong, E.2
Guyatt, G.H.3
King, D.4
Cook, D.J.5
Goldstein, R.S.6
-
12
-
-
0025886867
-
The St. George's Respiratory Questionnaire
-
Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31. [Discussion, 33-37.]
-
(1991)
Respir Med
, vol.85
, Issue.SUPPL. B
, pp. 25-31
-
-
Jones, P.W.1
Quirk, F.H.2
Baveystock, C.M.3
-
13
-
-
0030903442
-
Quality of life changes in COPD patients treated with salmeterol
-
Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155:1283-1289.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1283-1289
-
-
Jones, P.W.1
Bosh, T.K.2
-
14
-
-
0024854562
-
Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation
-
Jones PW, Baveystock CM, Littlejohns P. Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis 1989;140:1538-1543.
-
(1989)
Am Rev Respir Dis
, vol.140
, pp. 1538-1543
-
-
Jones, P.W.1
Baveystock, C.M.2
Littlejohns, P.3
-
15
-
-
0028588741
-
Using quality of life information to set priorities in health policy
-
Kaplan R. Using quality of life information to set priorities in health policy. Soc Indic Res 1994;33:121-163.
-
(1994)
Soc Indic Res
, vol.33
, pp. 121-163
-
-
Kaplan, R.1
-
16
-
-
0038440793
-
Methodological issues in evaluating measures of health as outcomes for COPD
-
Jones PW, Kaplan RM. Methodological issues in evaluating measures of health as outcomes for COPD. Eur Respir J Suppl 2003;41:13s-18s.
-
(2003)
Eur Respir J Suppl
, vol.41
-
-
Jones, P.W.1
Kaplan, R.M.2
-
17
-
-
0035035768
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary
-
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. 1256-1276
-
-
Pauwels, R.A.1
Buist, A.S.2
Calverley, P.M.3
Jenkins, C.R.4
Hurd, S.S.5
-
18
-
-
0023903301
-
Detection of emphysema with computed tomography: Correlation with pulmonary function tests and chest radiography
-
Sanders C, Nath PH, Bailey WC. Detection of emphysema with computed tomography: correlation with pulmonary function tests and chest radiography. Invest Radiol 1988;23:262-266.
-
(1988)
Invest Radiol
, vol.23
, pp. 262-266
-
-
Sanders, C.1
Nath, P.H.2
Bailey, W.C.3
-
19
-
-
0025764657
-
High resolution computed tomography in adult cystic fibrosis patients with mild lung disease
-
Santis G, Hodson ME, Strickland B. High resolution computed tomography in adult cystic fibrosis patients with mild lung disease. Clin Radiol 1991;44:20-22.
-
(1991)
Clin Radiol
, vol.44
, pp. 20-22
-
-
Santis, G.1
Hodson, M.E.2
Strickland, B.3
-
20
-
-
0030470881
-
New developments in anticholinergic drugs
-
Barnes P. New developments in anticholinergic drugs. Eur Respir Rev 1996;6:290-294.
-
(1996)
Eur Respir Rev
, vol.6
, pp. 290-294
-
-
Barnes, P.1
-
21
-
-
0028827084
-
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
-
American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S121.
-
(1995)
Am J Respir Crit Care Med
, vol.152
-
-
-
22
-
-
0041853629
-
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
-
Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW; for the ISOLDE Study Investigators. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58(8):659-664.
-
(2003)
Thorax
, vol.58
, Issue.8
, pp. 659-664
-
-
Calverley, P.M.1
Burge, P.S.2
Spencer, S.3
Anderson, J.A.4
Jones, P.W.5
-
23
-
-
21744444157
-
Bronchodilator response in the lung health study over 11 yrs
-
Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 2005;26:45-51.
-
(2005)
Eur Respir J
, vol.26
, pp. 45-51
-
-
Anthonisen, N.R.1
Lindgren, P.G.2
Tashkin, D.P.3
Kanner, R.E.4
Scanlon, P.D.5
Connett, J.E.6
-
24
-
-
20144382361
-
Minimal clinically important differences in COPD lung function
-
Donohue J. Minimal clinically important differences in COPD lung function. COPD: J Chron Obstruct Pulmon Dis 2005;2:111-124.
-
(2005)
COPD: J Chron Obstruct Pulmon Dis
, vol.2
, pp. 111-124
-
-
Donohue, J.1
-
25
-
-
0030012048
-
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease
-
Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:967-975.
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 967-975
-
-
Belman, M.J.1
Botnick, W.C.2
Shin, J.W.3
-
26
-
-
0032778472
-
Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
-
O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-549.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 542-549
-
-
O'Donnell, D.E.1
Lam, M.2
Webb, K.A.3
-
27
-
-
2542603339
-
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
-
O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840.
-
(2004)
Eur Respir J
, vol.23
, pp. 832-840
-
-
O'Donnell, D.E.1
Fluge, T.2
Gerken, F.3
Hamilton, A.4
Webb, K.5
Aguilaniu, B.6
Make, B.7
Magnussen, H.8
-
28
-
-
0036206421
-
Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation
-
Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002;121:1042-1050.
-
(2002)
Chest
, vol.121
, pp. 1042-1050
-
-
Newton, M.F.1
O'Donnell, D.E.2
Forkert, L.3
-
29
-
-
0035691634
-
Evaluation of bronchodilator responses in patients with "irreversible" emphysema
-
O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J 2001;18:914-920.
-
(2001)
Eur Respir J
, vol.18
, pp. 914-920
-
-
O'Donnell, D.E.1
Forkert, L.2
Webb, K.A.3
-
30
-
-
0023621216
-
Bronchodilators in chronic air-flow limitation: Effects on airway function, exercise capacity, and quality of life
-
Guyatt GH, Townsend M, Pugsley SO, Keller JL, Short HD, Taylor DW, Newhouse MT. Bronchodilators in chronic air-flow limitation: effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis 1987;135:1069-1074.
-
(1987)
Am Rev Respir Dis
, vol.135
, pp. 1069-1074
-
-
Guyatt, G.H.1
Townsend, M.2
Pugsley, S.O.3
Keller, J.L.4
Short, H.D.5
Taylor, D.W.6
Newhouse, M.T.7
-
31
-
-
0029936277
-
Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials
-
Rennard SI, Serby CW, Ghafouri M, Johnson PA, Friedman M. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest 1996;110:62-70.
-
(1996)
Chest
, vol.110
, pp. 62-70
-
-
Rennard, S.I.1
Serby, C.W.2
Ghafouri, M.3
Johnson, P.A.4
Friedman, M.5
-
32
-
-
0037425745
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial
-
Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449-456.
-
(2003)
Lancet
, vol.361
, pp. 449-456
-
-
Calverley, P.1
Pauwels, R.2
Vestbo, J.3
Jones, P.4
Pride, N.5
Gulsvik, A.6
Anderson, J.7
Maden, C.8
-
33
-
-
0037246566
-
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
-
Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003;21:74-81.
-
(2003)
Eur Respir J
, vol.21
, pp. 74-81
-
-
Szafranski, W.1
Cukier, A.2
Ramirez, A.3
Menga, G.4
Sansores, R.5
Nahabedian, S.6
Peterson, S.7
Olsson, H.8
-
34
-
-
0347473812
-
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
-
Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003;22:912-919.
-
(2003)
Eur Respir J
, vol.22
, pp. 912-919
-
-
Calverley, P.M.1
Boonsawat, W.2
Cseke, Z.3
Zhong, N.4
Peterson, S.5
Olsson, H.6
-
35
-
-
0038366897
-
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
-
Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003;58:399-404.
-
(2003)
Thorax
, vol.58
, pp. 399-404
-
-
Brusasco, V.1
Hodder, R.2
Miravitlles, M.3
Korducki, L.4
Towse, L.5
Kesten, S.6
-
36
-
-
0036181956
-
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
-
Casaburi R, Mahler DA, Jones PW, Wanner A, San Pedro G, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217-224.
-
(2002)
Eur Respir J
, vol.19
, pp. 217-224
-
-
Casaburi, R.1
Mahler, D.A.2
Jones, P.W.3
Wanner, A.4
San Pedro, G.5
ZuWallack, R.L.6
Menjoge, S.S.7
Serby, C.W.8
Witek Jr., T.9
-
38
-
-
0034061777
-
Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease
-
Lams BE, Sousa AR, Rees PJ, Lee TH. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000;15:512-516.
-
(2000)
Eur Respir J
, vol.15
, pp. 512-516
-
-
Lams, B.E.1
Sousa, A.R.2
Rees, P.J.3
Lee, T.H.4
-
39
-
-
0032014542
-
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease
-
Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:822-826.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 822-826
-
-
Saetta, M.1
Di Stefano, A.2
Turato, G.3
Facchini, F.M.4
Corbino, L.5
Mapp, C.E.6
Maestrelli, P.7
Ciaccia, A.8
Fabbri, L.M.9
-
40
-
-
0032798485
-
CD8+ cells in the lungs of smokers with chronic obstructive pulmonary disease
-
Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, et al. CD8+ cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:711-717.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 711-717
-
-
Saetta, M.1
Baraldo, S.2
Corbino, L.3
Turato, G.4
Braccioni, F.5
Rea, F.6
Cavallesco, G.7
Tropeano, G.8
Mapp, C.E.9
Maestrelli, P.10
-
41
-
-
0030071687
-
Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma
-
Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-534.
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 530-534
-
-
Keatings, V.M.1
Collins, P.D.2
Scott, D.M.3
Barnes, P.J.4
-
42
-
-
0036839767
-
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: Soluble tumor necrosis factor receptors are increased in sputum
-
Vernooy JH, Kucukaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-1224.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 1218-1224
-
-
Vernooy, J.H.1
Kucukaycan, M.2
Jacobs, J.A.3
Chavannes, N.H.4
Buurman, W.A.5
Dentener, M.A.6
Wouters, E.F.7
-
43
-
-
0032696013
-
Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
-
Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1635-1639.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 1635-1639
-
-
Culpitt, S.V.1
Maziak, W.2
Loukidis, S.3
Nightingale, J.A.4
Matthews, J.L.5
Barnes, P.J.6
-
44
-
-
0036727142
-
Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue
-
Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK. Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 2002;57:799-803.
-
(2002)
Thorax
, vol.57
, pp. 799-803
-
-
Gizycki, M.J.1
Hattotuwa, K.L.2
Barnes, N.3
Jeffery, P.K.4
-
45
-
-
0036341048
-
Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness
-
Verhoeven GT, Hegmans JP, Mulder PG, Bogaard JM, Hoogsteden HC, Prins JB. Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness. Thorax 2002;57:694-700.
-
(2002)
Thorax
, vol.57
, pp. 694-700
-
-
Verhoeven, G.T.1
Hegmans, J.P.2
Mulder, P.G.3
Bogaard, J.M.4
Hoogsteden, H.C.5
Prins, J.B.6
-
46
-
-
0034643610
-
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
-
Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320:1297-1303.
-
(2000)
BMJ
, vol.320
, pp. 1297-1303
-
-
Burge, P.S.1
Calverley, P.M.2
Jones, P.W.3
Spencer, S.4
Anderson, J.A.5
Maslen, T.K.6
-
47
-
-
0036153433
-
Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids
-
Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 2002;19:182-191.
-
(2002)
Eur Respir J
, vol.19
, pp. 182-191
-
-
Barnes, P.J.1
-
48
-
-
0037180086
-
Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling
-
Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002;360:1293-1299.
-
(2002)
Lancet
, vol.360
, pp. 1293-1299
-
-
Roth, M.1
Johnson, P.R.2
Rudiger, J.J.3
King, G.G.4
Ge, Q.5
Burgess, J.K.6
Anderson, G.7
Tamm, M.8
Black, J.L.9
-
49
-
-
0028264310
-
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
-
Allen & Hanburys Limited UK Study Group
-
Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-224.
-
(1994)
Lancet
, vol.344
, pp. 219-224
-
-
Greening, A.P.1
Ind, P.W.2
Northfield, M.3
Shaw, G.4
-
50
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma
-
Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
-
Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
-
(1997)
N Engl J Med
, vol.337
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
Tattersfield, A.E.4
O'Byrne, P.5
Barnes, P.J.6
Ullman, A.7
-
51
-
-
0036899028
-
Chronic obstructive pulmonary disease. 5: Systemic effects of COPD
-
Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002;57:1067-1070.
-
(2002)
Thorax
, vol.57
, pp. 1067-1070
-
-
Wouters, E.F.1
-
52
-
-
0028032187
-
Randomised controlled trial of respiratory rehabilitation
-
Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised controlled trial of respiratory rehabilitation. Lancet 1994;344:1394-1397.
-
(1994)
Lancet
, vol.344
, pp. 1394-1397
-
-
Goldstein, R.S.1
Gort, E.H.2
Stubbing, D.3
Avendano, M.A.4
Guyatt, G.H.5
-
53
-
-
0034728079
-
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial
-
Griffiths TL, Burr ML, Campbell IA, Lewis Jenkins V, Mullins J, Shiels K, Turner Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-368.
-
(2000)
Lancet
, vol.355
, pp. 362-368
-
-
Griffiths, T.L.1
Burr, M.L.2
Campbell, I.A.3
Lewis Jenkins, V.4
Mullins, J.5
Shiels, K.6
Turner Lawlor, P.J.7
Payne, N.8
Newcombe, R.G.9
Ionescu, A.A.10
-
54
-
-
0034881290
-
The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: A randomized controlled trial
-
Finnerty JP, Keeping I, Bullough I, Jones J. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. Chest 2001;119:1705-1710.
-
(2001)
Chest
, vol.119
, pp. 1705-1710
-
-
Finnerty, J.P.1
Keeping, I.2
Bullough, I.3
Jones, J.4
-
55
-
-
0030807009
-
Body composition and health-related quality of life in patients with obstructive airways disease
-
Shoup R, Dalsky G, Warner S, Davies M, Connors M, Khan M, Khan F, ZuWallack R. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 1997;10:1576-1580.
-
(1997)
Eur Respir J
, vol.10
, pp. 1576-1580
-
-
Shoup, R.1
Dalsky, G.2
Warner, S.3
Davies, M.4
Connors, M.5
Khan, M.6
Khan, F.7
Zuwallack, R.8
-
56
-
-
0033804346
-
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease
-
Mostert R, Goris A, Weling Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-867.
-
(2000)
Respir Med
, vol.94
, pp. 859-867
-
-
Mostert, R.1
Goris, A.2
Weling Scheepers, C.3
Wouters, E.F.4
Schols, A.M.5
-
57
-
-
2942720459
-
Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD
-
Franssen FM, Broekhuizen R, Janssen PP, Wouters EF, Schols AM. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest 2004;125:2021-2028.
-
(2004)
Chest
, vol.125
, pp. 2021-2028
-
-
Franssen, F.M.1
Broekhuizen, R.2
Janssen, P.P.3
Wouters, E.F.4
Schols, A.M.5
-
58
-
-
0033060006
-
Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease
-
Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, Barbera JA, Nadal J, de Jover L, Rodriguez Roisin R, et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1726-1734.
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 1726-1734
-
-
Sala, E.1
Roca, J.2
Marrades, R.M.3
Alonso, J.4
Gonzalez De Suso, J.M.5
Moreno, A.6
Barbera, J.A.7
Nadal, J.8
De Jover, L.9
Rodriguez Roisin, R.10
-
59
-
-
0033062424
-
Aerobic and strength training in patients with chronic obstructive pulmonary disease
-
Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C, Carrier G, Maltais F. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:896-901.
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 896-901
-
-
Bernard, S.1
Whittom, F.2
Leblanc, P.3
Jobin, J.4
Belleau, R.5
Berube, C.6
Carrier, G.7
Maltais, F.8
-
60
-
-
9444290721
-
Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease
-
Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154(2 Pt 1):442-447.
-
(1996)
Am J Respir Crit Care Med
, vol.154
, Issue.2 PART 1
, pp. 442-447
-
-
Maltais, F.1
LeBlanc, P.2
Simard, C.3
Jobin, J.4
Berube, C.5
Bruneau, J.6
Carrier, L.7
Belleau, R.8
-
61
-
-
0028863598
-
The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation
-
O'Donnell D, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 1995;152:2005-2013.
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 2005-2013
-
-
O'Donnell, D.1
McGuire, M.2
Samis, L.3
Webb, K.A.4
-
62
-
-
0030042996
-
Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patient with COPD
-
Maltais F, Simard A, Simard C, Jobin J, Desgagnés P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patient with COPD. Am J Respir Crit Care Med 1996;153:288-293.
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 288-293
-
-
Maltais, F.1
Simard, A.2
Simard, C.3
Jobin, J.4
Desgagnés, P.5
LeBlanc, P.6
-
63
-
-
0031685110
-
Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease
-
Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-1474.
-
(1998)
Med Sci Sports Exerc
, vol.30
, pp. 1467-1474
-
-
Whittom, F.1
Jobin, J.2
Simard, P.M.3
Leblanc, P.4
Simard, C.5
Bernard, S.6
Belleau, R.7
Maltais, F.8
-
64
-
-
3142517968
-
Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis
-
Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580.
-
(2004)
Thorax
, vol.59
, pp. 574-580
-
-
Gan, W.Q.1
Man, S.F.2
Senthilselvan, A.3
Sin, D.D.4
-
65
-
-
30844447198
-
Elevated CRP levels mark metabolic and functional impairment in advanced COPD
-
Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Elevated CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006;61:17-22.
-
(2006)
Thorax
, vol.61
, pp. 17-22
-
-
Broekhuizen, R.1
Wouters, E.F.2
Creutzberg, E.C.3
Schols, A.M.4
-
66
-
-
0031946651
-
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
-
Dev D, Wallace E, Sankaran R, Cunniffe J, Govan JR, Wathen CG, Emmanuel FX. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med 1998;92:664-667.
-
(1998)
Respir Med
, vol.92
, pp. 664-667
-
-
Dev, D.1
Wallace, E.2
Sankaran, R.3
Cunniffe, J.4
Govan, J.R.5
Wathen, C.G.6
Emmanuel, F.X.7
-
67
-
-
3242773943
-
C-reactive protein and body mass index predict outcome in endstage respiratory failure
-
Cano NJ, Pichard C, Roth H, Court-Fortune I, Cynober L, Gerard-Boncompain M, Cuvelier A, Laaban JP, Melchior JC, Raphael JC, et al. C-reactive protein and body mass index predict outcome in endstage respiratory failure. Chest 2004;126:540-546.
-
(2004)
Chest
, vol.126
, pp. 540-546
-
-
Cano, N.J.1
Pichard, C.2
Roth, H.3
Court-Fortune, I.4
Cynober, L.5
Gerard-Boncompain, M.6
Cuvelier, A.7
Laaban, J.P.8
Melchior, J.C.9
Raphael, J.C.10
-
68
-
-
0037465734
-
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
-
Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-1519.
-
(2003)
Circulation
, vol.107
, pp. 1514-1519
-
-
Sin, D.D.1
Man, S.F.2
-
69
-
-
0029787450
-
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
-
Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51(8):819-824.
-
(1996)
Thorax
, vol.51
, Issue.8
, pp. 819-824
-
-
Schols, A.M.1
Buurman, W.A.2
Staal Van Den Brekel, A.J.3
Dentener, M.A.4
Wouters, E.F.5
-
70
-
-
0035888760
-
Inflammatory response and body composition in chronic obstructive pulmonary disease
-
Eid AA, Ionescu AA, Nixon LS, Lewis Jenkins V, Matthews SB, Griffiths TL, Shale DJ. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-1418.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 1414-1418
-
-
Eid, A.A.1
Ionescu, A.A.2
Nixon, L.S.3
Lewis Jenkins, V.4
Matthews, S.B.5
Griffiths, T.L.6
Shale, D.J.7
-
71
-
-
0034677177
-
Tumor necrosis factor alpha stimulates osteoclast differentiation by amechanism independent of the ODF/RANKL-RANK interaction
-
Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by amechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000;191:275-286.
-
(2000)
J Exp Med
, vol.191
, pp. 275-286
-
-
Kobayashi, K.1
Takahashi, N.2
Jimi, E.3
Udagawa, N.4
Takami, M.5
Kotake, S.6
Nakagawa, N.7
Kinosaki, M.8
Yamaguchi, K.9
Shima, N.10
-
72
-
-
0034469421
-
Mechanisms of bone loss in inflammatory arthritis: Diagnosis and therapeutic implications
-
Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2000;2:33-37.
-
(2000)
Arthritis Res
, vol.2
, pp. 33-37
-
-
Goldring, S.R.1
Gravallese, E.M.2
-
73
-
-
10644288504
-
Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease
-
Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, Nixon LS, Evans WD, Griffiths TL, Shale DJ. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-1293.
-
(2004)
Am J Respir Crit Care Med
, vol.170
, pp. 1286-1293
-
-
Bolton, C.E.1
Ionescu, A.A.2
Shiels, K.M.3
Pettit, R.J.4
Edwards, P.H.5
Stone, M.D.6
Nixon, L.S.7
Evans, W.D.8
Griffiths, T.L.9
Shale, D.J.10
-
74
-
-
17244373523
-
The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature
-
Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-1959.
-
(2005)
Chest
, vol.127
, pp. 1952-1959
-
-
Sin, D.D.1
Wu, L.2
Man, S.F.3
-
75
-
-
0030752487
-
Oxidative stress in chronic obstructive pulmonary disease
-
Oxidative Stress Study Group
-
Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997;156:341-357.
-
(1997)
Am J Respir Crit Care Med
, vol.156
, pp. 341-357
-
-
Repine, J.E.1
Bast, A.2
Lankhorst, I.3
-
77
-
-
0037485683
-
Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients
-
Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 2003;35:140-148.
-
(2003)
Free Radic Biol Med
, vol.35
, pp. 140-148
-
-
Hageman, G.J.1
Larik, I.2
Pennings, H.J.3
Haenen, G.R.4
Wouters, E.F.5
Bast, A.6
-
79
-
-
0036855413
-
Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats
-
Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 2002;137:761-770.
-
(2002)
Br J Pharmacol
, vol.137
, pp. 761-770
-
-
Chiarugi, A.1
-
80
-
-
16844364420
-
Oxidative stress and airway inflammation in severe exacerbations of COPD
-
Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005;60:293-300.
-
(2005)
Thorax
, vol.60
, pp. 293-300
-
-
Drost, E.M.1
Skwarski, K.M.2
Sauleda, J.3
Soler, N.4
Roca, J.5
Agusti, A.6
MacNee, W.7
-
81
-
-
0033485301
-
Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: A self-protective mechanism?
-
Grant RS, Passey R, Matanovic G, Smythe G, Kapoor V. Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism? Arch Biochem Biophys 1999;372:1-7.
-
(1999)
Arch Biochem Biophys
, vol.372
, pp. 1-7
-
-
Grant, R.S.1
Passey, R.2
Matanovic, G.3
Smythe, G.4
Kapoor, V.5
-
82
-
-
0025155689
-
Adaptive changes in NAD+ metabolism in ultraviolet light-irradiated murine lymphoma cells
-
Kleczkowska HE, Szumiel I, Althaus FR. Adaptive changes in NAD+ metabolism in ultraviolet light-irradiated murine lymphoma cells. Cell Biol Toxicol 1990;6:259-268.
-
(1990)
Cell Biol Toxicol
, vol.6
, pp. 259-268
-
-
Kleczkowska, H.E.1
Szumiel, I.2
Althaus, F.R.3
-
83
-
-
0031889510
-
Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease
-
Pouw EM, Schols AM, van der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:453-457.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 453-457
-
-
Pouw, E.M.1
Schols, A.M.2
Van Der Vusse, G.J.3
Wouters, E.F.4
-
84
-
-
0023951085
-
Respiratory muscles and dyspnea
-
Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clin Chest Med 1988;9:237-248.
-
(1988)
Clin Chest Med
, vol.9
, pp. 237-248
-
-
Killian, K.J.1
Jones, N.L.2
-
85
-
-
0029118877
-
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: A placebo-controlled randomized trial
-
Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo-controlled randomized trial. Am J Respir Crit Care Med 1995;152:1268-1274.
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 1268-1274
-
-
Schols, A.M.1
Soeters, P.B.2
Mostert, R.3
Pluymers, R.J.4
Wouters, E.F.5
-
86
-
-
0037317984
-
Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease
-
Creutzberg EC, Wouters EF, Mostert R, Weling-Scheepers CA, Schols AM. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003;19:120-127.
-
(2003)
Nutrition
, vol.19
, pp. 120-127
-
-
Creutzberg, E.C.1
Wouters, E.F.2
Mostert, R.3
Weling-Scheepers, C.A.4
Schols, A.M.5
-
87
-
-
3242772924
-
High-sensitivity C-reactive protein: Clinical importance
-
Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004;29:439-493.
-
(2004)
Curr Probl Cardiol
, vol.29
, pp. 439-493
-
-
Bassuk, S.S.1
Rifai, N.2
Ridker, P.M.3
-
88
-
-
0037446333
-
Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress
-
Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 2003;34:1006-1016.
-
(2003)
Free Radic Biol Med
, vol.34
, pp. 1006-1016
-
-
Komatsu, W.1
Ishihara, K.2
Murata, M.3
Saito, H.4
Shinohara, K.5
-
89
-
-
18844415634
-
Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease
-
Broekhuizen R, Wouters EF, Creutzberg EC, Weling-Scheepers CA, Schols AM. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 2005;60:376-382.
-
(2005)
Thorax
, vol.60
, pp. 376-382
-
-
Broekhuizen, R.1
Wouters, E.F.2
Creutzberg, E.C.3
Weling-Scheepers, C.A.4
Schols, A.M.5
-
90
-
-
0024406369
-
Final report on the aspirin component of the ongoing Physicians' Health Study
-
Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.
-
(1989)
N Engl J Med
, vol.321
, pp. 129-135
-
-
-
91
-
-
0023845856
-
Randomised trial of prophylactic daily aspirin in British male doctors
-
Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988;296:313-316.
-
(1988)
Br Med J (Clin Res Ed)
, vol.296
, pp. 313-316
-
-
Peto, R.1
Gray, R.2
Collins, R.3
Wheatley, K.4
Hennekens, C.5
Jamrozik, K.6
Warlow, C.7
Hafner, B.8
Thompson, E.9
Norton, S.10
-
92
-
-
0032562005
-
Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
-
The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998;351:233-241.
-
(1998)
Lancet
, vol.351
, pp. 233-241
-
-
-
93
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
HOT Study Group
-
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
94
-
-
0035852471
-
Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
-
Collaborative Group of the Primary Prevention Project
-
de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001;357:89-95.
-
(2001)
Lancet
, vol.357
, pp. 89-95
-
-
De Gaetano, G.1
-
95
-
-
15744378579
-
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
-
Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-1304.
-
(2005)
N Engl J Med
, vol.352
, pp. 1293-1304
-
-
Ridker, P.M.1
Cook, N.R.2
Lee, I.M.3
Gordon, D.4
Gaziano, J.M.5
Manson, J.E.6
Hennekens, C.H.7
Buring, J.E.8
-
96
-
-
17244371786
-
Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease?
-
Sin DD, Man SF. Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease? Eur Respir J 2005;25:589-590.
-
(2005)
Eur Respir J
, vol.25
, pp. 589-590
-
-
Sin, D.D.1
Man, S.F.2
-
97
-
-
0023938335
-
The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response
-
Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988;9:222-229.
-
(1988)
Immunol Today
, vol.9
, pp. 222-229
-
-
Kammer, G.M.1
-
98
-
-
0035188826
-
Cyclic nucleotide phosphodiesterases
-
Essayan DM. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 2001;108:671-680.
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 671-680
-
-
Essayan, D.M.1
-
99
-
-
0034045949
-
Inhibition of p38 MAP kinase as a therapeutic strategy
-
Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000;47:185-201.
-
(2000)
Immunopharmacology
, vol.47
, pp. 185-201
-
-
Lee, J.C.1
Kumar, S.2
Griswold, D.E.3
Underwood, D.C.4
Votta, B.J.5
Adams, J.L.6
-
100
-
-
23744498786
-
First study of infliximab treatment in patients with chronic obstructive pulmonary disease
-
van der Vaart H, Koeter GH, Postma DS, Kauffman HF, ten Hacken NH. First study of infliximab treatment in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:465-469.
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 465-469
-
-
Van Der Vaart, H.1
Koeter, G.H.2
Postma, D.S.3
Kauffman, H.F.4
Ten Hacken, N.H.5
|